Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6022

Ipsen is no longer advancing Sutro’s ADC; Layoffs at Tune Therapeutics

$
0
0
Plus, news about Palisade Bio, Rocket, 10x Genomics, Oxurion, Eledon and Boehringer Ingelheim: Ipsen walks away from Sutro’s solid tumor drug: The French drugmaker

Viewing all articles
Browse latest Browse all 6022

Trending Articles